BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12403032)

  • 1. A blind parallel comparative study of the efficacy and safety of rovamycin versus augmentin in the treatment of acute otitis media.
    Mgbor NC; Umeh RE
    West Afr J Med; 2002; 21(2):117-20. PubMed ID: 12403032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
    Aggarwal M; Sinha R; Murali MV; Trihan P; Singhal PK
    Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
    Dunne MW; Latiolais T; Lewis B; Pistorius B; Bottenfield G; Moore WH; Garrett A; Stewart TD; Aoki J; Spiegel C; Boettger D; Shemer A
    J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group.
    Damrikarnlert L; Jauregui AC; Kzadri M
    J Chemother; 2000 Feb; 12(1):79-87. PubMed ID: 10768519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
    Noel GJ; Blumer JL; Pichichero ME; Hedrick JA; Schwartz RH; Balis DA; Melkote R; Bagchi P; Arguedas A
    Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Arguedas A; Soley C; Kamicker BJ; Jorgensen DM
    Int J Infect Dis; 2011 Apr; 15(4):e240-8. PubMed ID: 21269858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children.
    Casellas JM; Israele V; Marín M; Ishida MT; Heguilen R; Soutric J; Arenoso H; Sibbald A; Stamboulian D
    Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1225-33. PubMed ID: 16061111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, observer-blind trial of amoxycillin/clavulanate versus cefaclor in the treatment of children with acute otitis media. Augmentin 415 Study Group.
    Subba Rao SD; Macias MP; Dillman CA; Ramos BD; Kierszenbaum JS; Soliman AE
    J Chemother; 1998 Dec; 10(6):460-8. PubMed ID: 9876054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
    Poachanukoon O; Kitcharoensakkul M
    Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
    Block SL; Schmier JK; Notario GF; Akinlade BK; Busman TA; Mackinnon GE; Halpern MT; Nilius AM
    Curr Med Res Opin; 2006 Sep; 22(9):1839-47. PubMed ID: 16968587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
    Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.
    Bucher HC; Tschudi P; Young J; Périat P; Welge-Lüussen A; Züst H; Schindler C;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1793-8. PubMed ID: 12912714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of rovamycin and amox-clav in patients with infectious-inflammatory pathology of the ORL organs].
    Kriukov AI; Poliakova TS; Ogorodnikov DS; Gaĭvoronskaia GA
    Vestn Otorinolaringol; 1996; (2):42-5. PubMed ID: 8711846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of acute non-chlamydial salpingitis. Study of the efficacy and tolerance of a single-therapy antibiotic: Augmentin].
    Tison E; Marpeau L; Pigné A; Tessier F; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(4):513-9. PubMed ID: 3209830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rovamycin (spiramycin)--a macrolide antibiotic for intravenous administration: a trial in the treatment of pneumonia].
    Strachunskiĭ LS; Sudilovskaia NN; Melikhov OG
    Ter Arkh; 1995; 67(3):7-11. PubMed ID: 7770811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
    Dagan R
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with rovamycin and roxithromycin in patients with chronic bronchitis in the presence of posttuberculous changes].
    Sobeleva LG; Komlev AD; Korovina OV
    Probl Tuberk; 2002; (2):27-9. PubMed ID: 11899800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is acute otitis media a treatable disease?
    Klein JO
    N Engl J Med; 2011 Jan; 364(2):168-9. PubMed ID: 21226583
    [No Abstract]   [Full Text] [Related]  

  • 20. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.